β-Catenin mutations in recurrent FIGO IA grade i endometrioid endometrial cancers

Gynecologic Oncology

Volumn 134, Issue 2, 2014, Pages 426-427

  Myers, Andrea ^a   Barry, William T ^a   Hirsch, Michelle S ^b   Matulonis, Ursula ^a   Lee, Larissa ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; BETA CATENIN; CARCINOMA, ENDOMETRIOID; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MUTATION; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES;

EID: 84905569850     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.06.010     Document Type: Letter

References (5)

1. C. Kandoth, N. Schultz, A.D. Cherniack, R. Akbani, Y. Liu, and H. Shen et al. Integrated genomic characterization of endometrial carcinoma Nature 497 7447 2013 67 73 [Epub 2013/05/03]
2. H.M. Keys, J.A. Roberts, V.L. Brunetto, R.J. Zaino, N.M. Spirtos, and J.D. Bloss et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol Oncol 92 3 2004 744 751 [Epub 2004/02/27]
3. L.E. MacConaill, C.D. Campbell, S.M. Kehoe, A.J. Bass, C. Hatton, and L. Niu et al. Profiling critical cancer gene mutations in clinical tumor samples PLoS One 4 11 2009 e7887 [Epub 2009/11/20]
4. R.A. Nout, T. Bosse, C.L. Creutzberg, I.M. Jurgenliemk-Schulz, J.J. Jobsen, and L.C. Lutgens et al. Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation Gynecol Oncol 126 3 2012 466 473 [Epub 2012/05/23]
5. I.M. Stefansson, H.B. Salvesen, and L.A. Akslen Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer J Clin Oncol 22 7 2004 1242 1252 [Epub 2004/03/31]